146 related articles for article (PubMed ID: 35147468)
1. A Field Placement Approach to Enhance State and Local Capacity for Opioid-Related Issues Affecting Pregnant and Postpartum People and Infants Prenatally Exposed to Opioids and Other Substances.
Weber MK; Tran EL; Kroelinger CD; Ellison C; Mueller T; Romero L; Ellick KL; Rice ME; Garcia G; Pliska E; Akbarali S; Dronamraju R; Patterson K; Fehrenbach SN; Barfield WD
J Womens Health (Larchmt); 2022 Feb; 31(2):145-153. PubMed ID: 35147468
[TBL] [Abstract][Full Text] [Related]
2. Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community.
Kroelinger CD; Addison D; Rodriguez M; Rice ME; Frey MT; Hickner HR; Weber MK; Mueller T; Velonis A; Uesugi K; Romero L; Akbarali S; Foster N; Ko JY; Pliska E; Mackie C; Cox S; Fehrenbach SN; Barfield WD
J Womens Health (Larchmt); 2020 Apr; 29(4):475-486. PubMed ID: 32176568
[TBL] [Abstract][Full Text] [Related]
3. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.
Kroelinger CD; Rice ME; Cox S; Hickner HR; Weber MK; Romero L; Ko JY; Addison D; Mueller T; Shapiro-Mendoza C; Fehrenbach SN; Honein MA; Barfield WD
MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(36):777-783. PubMed ID: 31513558
[TBL] [Abstract][Full Text] [Related]
4. Increasing access to quality care for pregnant and postpartum people with opioid use disorder: Coordination of services, provider awareness and training, extended postpartum coverage, and perinatal quality collaboratives.
Ellick KL; Kroelinger CD; Chang K; McGown M; McReynolds M; Velonis AJ; Bronson E; Riehle-Colarusso T; Pliska E; Akbarali S; Mueller T; Dronamraju R; Cox S; Barfield WD
J Subst Use Addict Treat; 2024 Jan; 156():209208. PubMed ID: 37939904
[TBL] [Abstract][Full Text] [Related]
5. Assessing Sustainability of State-Led Action Plans for the Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community, 2018-2021.
Kroelinger CD; Ellick KL; Levecke M; Rice ME; Mueller T; Akbarali S; Pliska E; Ko JY; Cox S; Barfield WD
J Womens Health (Larchmt); 2023 May; 32(5):503-512. PubMed ID: 37159557
[No Abstract] [Full Text] [Related]
6. Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol.
Bryan MA; Smid MC; Cheng M; Fortenberry KT; Kenney A; Muniyappa B; Pendergrass D; Gordon AJ; Cochran G
Addict Sci Clin Pract; 2020 Oct; 15(1):33. PubMed ID: 33129355
[TBL] [Abstract][Full Text] [Related]
7. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of State-Led Surveillance of Neonatal Abstinence Syndrome - Six U.S. States, 2018-2021.
Jilani SM; West K; Jacobus-Kantor L; Ali MM; Nyakeriga A; Lake-Burger H; Robinson M; Barnes AE; Jewell T; Gallaway S
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):37-42. PubMed ID: 35025857
[TBL] [Abstract][Full Text] [Related]
9. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome.
Ko JY; Wolicki S; Barfield WD; Patrick SW; Broussard CS; Yonkers KA; Naimon R; Iskander J
MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(9):242-245. PubMed ID: 28278146
[TBL] [Abstract][Full Text] [Related]
10. The MATernaL and Infant NetworK to Understand Outcomes Associated with Treatment of Opioid Use Disorder During Pregnancy (MAT-LINK): Surveillance Opportunity.
Tran EL; Kim SY; England LJ; Green C; Dang EP; Broussard CS; Fehrenbach N; Hudson A; Yowe-Conley T; Gilboa SM; Meaney-Delman D
J Womens Health (Larchmt); 2020 Dec; 29(12):1491-1499. PubMed ID: 33227221
[TBL] [Abstract][Full Text] [Related]
11. Federal and State Policy Efforts to Address Maternal Opioid Misuse: Gaps and Challenges.
Saunders JB; Jarlenski MP; Levy R; Kozhimannil KB
Womens Health Issues; 2018; 28(2):130-136. PubMed ID: 29183818
[TBL] [Abstract][Full Text] [Related]
12. Clinical Opinion Letters Regarding Breastfeeding and Neonatal Abstinence Syndrome for Child Apprehension Family Court Proceedings.
Paynter MJ
J Hum Lact; 2019 May; 35(2):349-353. PubMed ID: 30543758
[TBL] [Abstract][Full Text] [Related]
13. Impact of maternal medication for opioid use disorder on neurodevelopmental outcomes of infants treated for neonatal opioid withdrawal syndrome.
King RS; Peacock-Chambers E; Wilson D; Shimer J; Foss S; Visintainer P; Singh R
J Neonatal Perinatal Med; 2021; 14(4):463-473. PubMed ID: 33843701
[TBL] [Abstract][Full Text] [Related]
14. Policy perceptions of US state public health and child and family services regarding maternal opioid use and neonatal exposure.
Scott LF; Stone C; Duwve J
Arch Psychiatr Nurs; 2019 Oct; 33(5):22-30. PubMed ID: 31711589
[TBL] [Abstract][Full Text] [Related]
15. Opioid Use Disorder and Perinatal Outcomes.
Piske M; Homayra F; Min JE; Zhou H; Marchand C; Mead A; Ng J; Woolner M; Nosyk B
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34479983
[TBL] [Abstract][Full Text] [Related]
16. Rural communities face more than an opioid crisis: Reimagining funding assistance to address polysubstance use, associated health problems, and limited rural service capacity.
Carpenedo Mun C; Schuler H; Baker R; Byrne F; Bresani E; Meyers K
J Rural Health; 2023 Sep; 39(4):795-803. PubMed ID: 36775905
[TBL] [Abstract][Full Text] [Related]
17. Inclusion of Sex and Gender Differences in U.S. State Action Plans for Opioid Use and Opioid Use Disorder.
Goss T; Esguerra J; Newman C; Patrick J; Templeton K
J Womens Health (Larchmt); 2024 Mar; 33(3):275-282. PubMed ID: 38064491
[No Abstract] [Full Text] [Related]
18. Addressing the impact of opioids on women and children.
Bianchi DW; Gillman MW
Am J Obstet Gynecol; 2019 Aug; 221(2):123.e1-123.e4. PubMed ID: 31151658
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.
Dave CV; Goodin A; Zhu Y; Winterstein A; Wang X; Alrwisan A; Hartzema A
Pharmacotherapy; 2019 Oct; 39(10):1005-1011. PubMed ID: 31361913
[TBL] [Abstract][Full Text] [Related]
20. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
